Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1180 of 6351
-
Mind-Controlled glove could help stroke survivors move their hands again
Disease control Recruiting nowUpper extremity (UE) recovery remains a huge rehabilitation challenge with largely incomplete recovery of the upper limb post stroke. This is due to heavier priorities placed on other stroke competencies such as mobility, activities of daily living training and home integration w…
Sponsor: Tan Tock Seng Hospital • Aim: Disease control
Last updated Jun 26, 2026 15:00 UTC
-
Growth hormone may cut IV feeding needs for short bowel patients
Disease control Recruiting nowThis is a multicenter, open-label, single-arm clinical trial. A total of 100 participants with short bowel syndrome (SBS) receiving parenteral nutrition (PN) support are planned to be enrolled. The trial includes a 2-week run-in phase and a 4-week intervention phase, during which…
Phase 4 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New hope for breast cancer patients: drug may tame hot flashes without hormones
Symptom relief OngoingOne of the standard treatments for women with breast cancer is hormone therapy, but this treatment can cause hot flashes. Hormone replacement therapy, or HRT, is most often prescribed for hot flashes for women in menopause but cannot be given to women on hormone therapy for breas…
Phase 3 • Sponsor: Astellas Pharma Global Development, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
Spiritual healing for veterans: new therapy targets moral injury
Disease control By invitation onlyMoral Injury Syndrome (MIS) affects up to 35-60% of Veterans managing combat-related PTSD; it results from experiences that challenge deeply held values or spiritual beliefs. Symptoms of MIS may include hopelessness, helplessness, loss of spiritual beliefs, difficulty with forgiv…
Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
AI and mindfulness join forces to tackle chronic back pain
Symptom relief Recruiting nowThis study will identify unique signatures that people have which can cause pain by evaluating biological, psychological, and social markers using artificial intelligence. These markers can be used to accurately predict the response of diverse individuals with chronic low back pa…
Sponsor: Boston Medical Center • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
New pill aims to slow rare brain disease in landmark trial
Disease control OngoingPROSPER trial is a trial to assess the efficacy of FNP-223 in slowing disease progression in participants with PSP as measured by the PSP Rating Scale (PSPRS) over 52 weeks and to assess the safety and tolerability of FNP-223 for 52 weeks in participants with PSP.
Phase 2 • Sponsor: Ferrer Internacional S.A. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New drug plozasiran aims to tame dangerous fat levels in blood
Disease control OngoingThis Phase 3 study will evaluate the safety and efficacy of plozasiran injection (ARO-APOC3) in adult participants with severe hypertriglyceridemia (SHTG). After providing informed consent eligible participants will be randomized to receive 4 doses (once every 3 months) of plozas…
Phase 3 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New drug aims to calm relentless itch of prurigo nodularis
Symptom relief Stopped earlyThe main objective of the study will be to evaluate the efficacy of rocatinlimab compared with placebo at week 24 on the patient-reported outcome (PRO) measure of pruritus and overall clinical assessment score (US only).
Phase 3 • Sponsor: Amgen • Aim: Symptom relief
Last updated Jul 29, 2026 00:00 UTC
-
Can tailored rehab help long COVID patients get moving again?
Symptom relief CompletedThis is a platform protocol designed to be flexible so that it is suitable for a range of interventions and settings within diverse health care systems and community settings with incorporation into clinical COVID-19 management programs and treatment plans if results achieve key …
Sponsor: Duke University • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
Double drug attack: new hope for tough Crohn's cases?
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the efficacy and safety of dual-target therapy (Ustekinumab combined with Upadacitinib) versus intensified Ustekinumab monotherapy in patients with Crohn's disease who have an inadequate response to standard doses of Ustekinumab. The…
Phase 4 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Sound waves to the rescue: new device aims to heal legs and prevent amputation
Disease control OngoingCALCIO is a multicentre, prospective, observational cohort study that will collect real world data on the use of intravascular Lithotripsy (IVL) with the Shockwave IVL system to disrupt calcified femoropopliteal and crural lesions in patients with chronic limb-threatening ischemi…
Sponsor: Cardiovascular and Interventional Radiological Society of Europe • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New blood recycling method may cut bleeding in High-Risk heart surgery
Disease control Recruiting nowDespite significant advances in patient blood management, cardiac surgery remains a surgical procedure at high risk for bleeding. Numerous perioperative blood conservation strategies have been developed for limiting the use of blood products. Among them, the processing of shed bl…
Sponsor: University Hospital, Bordeaux • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New portable pump could let fistula patients ditch IV nutrition at home
Disease control Recruiting nowHigh-output enterocutaneous fistulas (HOF) and double enterostomies are severe complications of abdominal surgery or trauma. Double enterostomies are typically created after small bowel resection in fragile patients who cannot tolerate intestinal reconnection. Reconnection is gen…
Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Intermittent dieting may reverse early heart risks in kids
Disease control Recruiting nowThis randomized trial aims to evaluate the health-promoting effects of intermittent dietary restrictions, including intermittent low-carbohydrate diet (ILCD) and calorie restriction (ICR), in school-aged children with cardiometabolic risk (CMR) compared with general health educat…
Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
E-Cigarettes vs. medication: a new hope for stubborn smokers?
Disease control Recruiting nowThis study evaluates whether non-cigarette tobacco products (e-cigarettes) can help smokers quit smoking as compared to traditional quit methods (nicotine replacement therapy or varenicline/Chantix). Participants in this study will be randomly assigned to one of two groups, then …
Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Vitamin B6 could be a simple shield against postpartum depression
Prevention Recruiting nowPerinatal depression is a highly prevalent and serious health issue during pregnancy. According to statistics, approximately one out of every ten postpartum women experiences this condition. Symptoms can manifest as mood fluctuations or emotional lows. Unfortunately, these sympto…
Sponsor: National Taiwan University Hospital • Aim: Prevention
Last updated Jul 09, 2026 00:00 UTC
-
New hope for aggressive brain tumors: radioactive drug tested in small trial
Disease control CompletedPhase I open-label trial of 123I-ATT001 monotherapy and in combination with treatment therapies in subjects with relapsed glioblastoma.
Phase 1 • Sponsor: Theragnostics Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Could a common mineral slow Parkinson's? small trial hints at possibility
Disease control OngoingThis study will examine the effects of lithium 20mg/day compared to placebo on MRI and blood-based biomarkers among 20 early-stage Parkinson's disease patients.
Phase 1/2 • Sponsor: State University of New York at Buffalo • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
VR headset could replace eye patches for lazy eye in kids
Disease control Recruiting nowIn children 4 to 7 years of age, to determine if treatment with 1 hour per day 6 days per week of watching dichoptic movies/shows wearing the Luminopia headset is non-inferior to treatment with 2 hours of patching per day 7 days per week with respect to change in amblyopic eye di…
Phase 3 • Sponsor: Jaeb Center for Health Research • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Can a vacuum chamber help heal stubborn leg wounds?
Disease control CompletedThe goal of this clinical trial is to learn if vacuum compression therapy added to standard care improves wound healing in adults with chronic lower limb ulcers. The main questions it aims to answer are: * Does vacuum compression therapy lead to a greater reduction in wound vol…
Sponsor: BTL Industries Ltd. • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC